Ansa Biotechnologies, Inc.

CIK 1816722 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ansa Biotechnologies, Inc..

Recent SEC filings

FiledFormAccession number
Dec 10, 2025D/A0001231919-25-000593
Oct 2, 2025D0001231919-25-000275
May 5, 2022D/A0001816722-22-000002
Apr 14, 2022D0001816722-22-000001
Oct 15, 2021D0001816722-21-000001
Jul 9, 2020D0001816722-20-000001